IRIS
COMOLLI, GIUDITTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 407
EU - Europa 370
AS - Asia 182
SA - Sud America 5
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 966
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 398
IT - Italia 142
CN - Cina 117
IE - Irlanda 102
SG - Singapore 52
FI - Finlandia 39
DE - Germania 34
SE - Svezia 11
BE - Belgio 10
GB - Regno Unito 10
UA - Ucraina 8
CA - Canada 7
AT - Austria 4
BR - Brasile 4
IN - India 4
JP - Giappone 3
CZ - Repubblica Ceca 2
FR - Francia 2
LK - Sri Lanka 2
NL - Olanda 2
RU - Federazione Russa 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CL - Cile 1
GE - Georgia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
TR - Turchia 1
Totale 966
Salva come PNG Salva come JPEG
Città #
Dublin 98
Chandler 77
Singapore 40
Ashburn 38
Milan 38
New York 38
Pavia 34
Helsinki 33
Boardman 30
Ann Arbor 26
Shanghai 23
Beijing 20
Nanjing 18
Princeton 16
Jacksonville 13
Lawrence 13
Wilmington 13
Medford 10
Munich 10
Seattle 10
Rome 9
Brussels 8
Shenyang 8
Hebei 7
Nanchang 7
Los Angeles 6
Toronto 6
Frankfurt am Main 5
Corsico 4
Falls Church 4
Piscataway 4
Pune 4
Cascina 3
Hangzhou 3
Jinan 3
Santa Clara 3
Tokyo 3
Vigevano 3
Washington 3
Bereguardo 2
Brescia 2
Buccinasco 2
Changsha 2
Chengdu 2
Colombo 2
Jette 2
Jiaxing 2
Kemerovo 2
London 2
San Francisco 2
Serrone 2
Shenzhen 2
Tianjin 2
Turin 2
Verona 2
Woodbridge 2
Xi'an 2
Amsterdam 1
Baoding 1
Boves 1
Brno 1
Cacoal 1
Cambridge 1
Cascavel 1
Como 1
Dallas 1
Fairfield 1
Falkenstein 1
Ferrara di Monte Baldo 1
Guangzhou 1
Haifa 1
Hengyang 1
Istanbul 1
Jining 1
Lanzhou 1
Leawood 1
Luoyang 1
Motta Visconti 1
Naples 1
Norwalk 1
Nuremberg 1
Olomouc 1
Ottawa 1
Padova 1
Rio de Janeiro 1
Rovello Porro 1
San Diego 1
Santiago 1
Shijiazhuang 1
São João de Pirabas 1
Tbilisi 1
Tirana 1
Torreón 1
Totale 763
Salva come PNG Salva come JPEG
Nome #
Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation 92
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 65
Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. 64
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 64
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 59
Occult HIV infection in a large sample of health-care users in Lombardy, Italy in 2014-2015: Implications for control strategies 58
Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation. 50
Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells 49
Human Cytomegalovirus-Specific Memory CD4+T-Cell Response and Its Correlation with Virus Transmission to the Fetus in Pregnant Women with Primary Infection 46
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 46
Dengue Virus-Specific Humoral and T Cellular Immune Response in Italian Residents and Travelers Returning from Endemic Areas 40
Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay 38
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 35
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 34
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 31
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy 29
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 26
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 22
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers 22
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 22
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 20
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study 18
The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy 18
Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up 17
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 13
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay 8
Human Cytomegalovirus and Epstein-Barr virus specific immunity in patients with ulcerative colitis 7
Different Antigen-Specific CD4+ and CD8+ T-Cell Response against HCMV Proteins in Pregnant Women with Primary Infection and in Control Subjects with Remote Infection 3
Memory T cells specific for HBV enumerated by a peptide-based cultured enzyme-linked immunospot assay in healthy HBV-vaccinated subjects 2
Totale 998
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.083
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028 0 0 0 0 0 0 3 4 0 10 11 0
2020/202152 3 2 7 2 5 2 2 13 5 4 6 1
2021/202294 3 2 2 2 4 4 7 8 1 12 9 40
2022/2023284 17 27 2 18 12 19 0 7 120 2 55 5
2023/2024258 24 34 11 9 13 82 26 17 1 8 17 16
2024/2025184 17 34 9 45 13 47 19 0 0 0 0 0
Totale 998